gms | German Medical Science

71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

21.06. - 24.06.2020

The best time for prophylactic anticoagulation after subarachnoid haemorrhage – the earlier, the better?

Auf der Suche nach dem optimalen Zeitpunkt der prophylaktischen Antikoagulation nach subarachnoidaler Blutung – je eher, desto besser?

Meeting Abstract

  • presenting/speaker Annika Hantsche - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig, Deutschland
  • Florian Wilhelmy - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig, Deutschland
  • Dirk Lindner - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig, Deutschland
  • Jürgen Meixensberger - Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie, Leipzig, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. sine loco [digital], 21.-24.06.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocV233

doi: 10.3205/20dgnc163, urn:nbn:de:0183-20dgnc1635

Veröffentlicht: 26. Juni 2020

© 2020 Hantsche et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: In neurosurgery generally, and especially regarding subarachnoid hemorrhage (SAH) - being a severe and complex pathology with dreaded both ischemic and hemorrhagic complications - the optimal prophylactic heparin regimen is still controversial. The goal of this study was to analyse the impact of the timepoint of heparin initiation (ToH) on the incidence of ischemic and haemorrhagic events after SAH.

Methods: Patients who received acute treatment for non-traumatic SAH between 2011 and 2018 were considered for this retrospective study. 370 patients were included. The influence of the ToH on the incidence of ischemic and haemorrhagic events and changes in outcome scores was assessed. Therefore, the period between admission or, if possible, securing the source of bleeding (SOB) and ToH in hours was calculated. Statistical analysis was performed using Mann-Whitney U-Test, Chi-square test, Fisher’s exact test and univariate binomial logistic regression. P-values lower than 0.05 were considered statistically significant.

Results: The incidence of extracranial ischemia was 4.6%, thrombembolic intracranial ischemia 12.2% and intracranial re-bleeding 14.6%.The ToH as a continuous parameter significantly affects the incidence of extracranial ischemia (p=0.009), but does not have an impact on intracranial ischemia or rebleeding. Patients anticoagulated within 48 hours have a significantly lower incidence of extracranial ischemia than those with later ToH (p=0.020). Yet, the outcome at discharge did not diverge. When starting heparin later than 72h after admission or securing the SOB, extracranial ischemia occurs significantly more often (p=0.037), along with a significantly worse outcome at discharge (modified Rankin Scale (mRS) p=0.031, Glasgow Outcome Scale (GOS) p=0.026) and after 12 months (mRS p=0.014, GOS p=0.019), but without differences in mortality or readmission rates. No significant differences in the occurrence of initial World Federation of Neurosurgical Societies (WFNS) Scores above 3 could be detected between the time windows.

Conclusion: While later initiation of heparin is associated with higher incidence of extracranial ischemia, it does not influence the incidence of intracranial ischemia or intracranial re-bleeding. All patients suffering from SAH can therefore be administered heparin within 24 hours after admission or securing of SOB, respectively, as prophylactic doses do not promote re-bleeding.